According to GlobalData’s medical device pipeline database, 12 Cervical Total Disc Replacement Systems devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

Of these devices, five are in active development, while the remaining seven are in an inactive stage of development. There are two products in the early stages of development, and the remaining three are in the late stages of development.

Cervical Disc Arthroplasty is a surgical procedure during which an artificial disc is used to replace degenerated intervertebral discs. It is used for disc replacement in cervical region. The device includes upper endplate, spacer and lower endplate. One unit refers to one cervical total disc replacement system.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Cervical Total Disc Replacement Systems pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Cervical Total Disc Replacement Systems devices. Overall, most of these Cervical Total Disc Replacement Systems pipeline devices are being developed by private entities.

Key players involved in the active development of Cervical Total Disc Replacement Systems include ALCeraX Medizintechnik, Beijing Aikang Yicheng Medical Equipment, Meliora Medical, Mimesis Spine, Precision Spine, SeaSpine, Spineart Geneva, SpineSmith Holdings, Synergy Disc Replacement and Synergy Spine Solutions.

For a complete picture of the developmental pipeline for Cervical Total Disc Replacement Systems devices, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.